ArticlePloS one2025
Application of flexible parametric cure model in determination of effective factors on the technique of survival peritoneal dialysis patients in adults of Iran.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePeritoneal Dialysis (PD) is one of the most common methods of dialysis performed in patients with kidney failure. This study presents the application of flexible parametric cure models, which enhance fit and interpretability by accommodating various survival distributions and allowing for the estimation of the cured fraction in diverse populations. Thus, the purpose of this study is to determine the risk and demographic factors affecting the survival of non-cured dialysis patients undergoing peritoneal dialysis, as well as to estimate the cured fraction of survival using this method. METHODOLOGY: A total of 4,144 adult patients (aged 20 and above) were included in a retrospective (historical) cohort study from the Iranian PD registry, conducted between 1995 and 2018 across 20 centers nationwide. The study considered important variables such as sex, age, BMI, creatinine, calcium, cholesterol, triglycerides, Low-Density Lipoprotein (LDL), High-Density Lipoprotein (HDL), Erythrocyte Sedimentation Rate (ESR), systolic blood pressure (SBP), and diastolic blood pressure (DBP). A flexible parametric cure model was employed to assess the independent risk factors for PD technique failure.
findingsThe results of the current study showed that the flexible parametric cure Model (AIC = 5735.06) has a better fit compared with another cure model (mixture cure model = 6676.25, non-mixture cure model = 6677.28). Based on the findings of this study, the estimated cure fraction of survival using the PD method was 50% (95% CI: 0.47-0.53). The flexible cure model, demonstrated in a multivariate setting, indicated that variables such as age over 60 years (HR = 2.11, 95% CI: 1.05-1.35), calcium levels above 10.2 (HR = 1.43, 95% CI: 1.30-1.56), LDL levels above 140 (HR = 1.23 95% CI: 1.07-1.42), ESR (HR = 1.006, 95% CI: 1.003-1.01) and DBP (HR = 1.17, 95% CI: 1.16-1.31) significantly impacted the survival of non-cured patients.
conclusionThe presence of cured individuals in the data flattens the Kaplan-Meier curve. In such cases, employing a flexible parametric cure model is appropriate to separately investigate the effects of various factors on the cure fraction and the survival of susceptible individuals. The findings of this study indicated that age, calcium, LDL, ESR, and DBP significantly influenced the survival of non-cured individuals. Specifically, increases in these variables were associated with a higher risk of technique failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.